GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Pre-Tax Income

Taisho Pharmaceutical Holdings Co (TSE:4581) Pre-Tax Income : 円17,084 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Taisho Pharmaceutical Holdings Co's pretax income for the three months ended in Dec. 2023 was 円4,464 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was 円17,084 Mil. Taisho Pharmaceutical Holdings Co's pretax margin was 5.34%.

During the past 13 years, Taisho Pharmaceutical Holdings Co's highest Pretax Margin was 24.67%. The lowest was 5.23%. And the median was 13.09%.


Taisho Pharmaceutical Holdings Co Pre-Tax Income Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Pre-Tax Income Chart

Taisho Pharmaceutical Holdings Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64,484.00 29,775.00 22,976.00 21,398.00 29,498.00

Taisho Pharmaceutical Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,626.00 -402.00 7,098.00 5,924.00 4,464.00

Competitive Comparison of Taisho Pharmaceutical Holdings Co's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Taisho Pharmaceutical Holdings Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taisho Pharmaceutical Holdings Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taisho Pharmaceutical Holdings Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Taisho Pharmaceutical Holdings Co's Pre-Tax Income falls into.



Taisho Pharmaceutical Holdings Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Taisho Pharmaceutical Holdings Co's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=23019+0+-169+1592+5056
=29,498

Taisho Pharmaceutical Holdings Co's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=2656+0+-85+743+1150
=4,464

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円17,084 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taisho Pharmaceutical Holdings Co  (TSE:4581) Pre-Tax Income Explanation

Taisho Pharmaceutical Holdings Co's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=4464/83576
=5.34%

During the past 13 years, Taisho Pharmaceutical Holdings Co's highest Pretax Margin was 24.67%. The lowest was 5.23%. And the median was 13.09%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taisho Pharmaceutical Holdings Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Taisho Pharmaceutical Holdings Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Traded in Other Exchanges
Address
3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655
Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines